AnTenGager: Emerging Novel Second Generation TCE with Better Safety & Efficacy – Masking Technologies via Steric Hindrance
Time: 1:30 pm
day: Day One
Details:
- DAA bivalent binding for deeper depletions of the targeT-Cells
- Steric hindrance-based masking and DAA- gated CD3+ T-Cell activation
- Novel CD3 DE/EG binder with fast on/fast off binding kinetics
